minimally invasive surgery (MIS) for patients with a gynecologic cancer is not unique or without precedent having been previously addressed in endometrial cancer. The GOG performed a sentinel surgical trial for the management of early stage endometrial cancer, GOG LAP-2, which noted that minimally invasive surgery, as compared to traditional abdominal hysterectomy with surgical staging, appeared to be associated with similar oncologic outcomes with an overall survival of nearly 90% at 5-years for patients in both arms and uniformly less morbidity for women underdoing MIS (Walker et al., 2012; Walker et al., 2009 ).
Ramirez and colleagues are to be congratulated for taking the first step to address an extremely important question in women with cervical cancer. At present it remains to be seen if the accepted paradigm of MIS use in, or abandonment for, early stage cervical cancer will occur. We look forward to working to determine the ideal surgical management of women with early stage cervical cancer and call on the gynecologic cancer community to participate.
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